Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Risk of Persistent Renal Insufficiency in Premature Infants Following the Prenatal Use of Indomethacin for Suppression of Preterm Labor

Abstract

OBJECTIVE: To determine the risk of persistent renal insufficiency (RI) in premature infants following the use of antenatal indomethacin for suppression of preterm labor.

STUDY DESIGN: This population-based, retrospective review consisted of infants admitted during a 5-year period (1994–1999) to a tertiary referral neonatal intensive care nursery. Data were reviewed on 37 infants whose mothers received indomethacin for tocolysis, and on 37 matched controls. Renal insufficiency was defined as infant creatinine (Cr) ≥1.5 mg/dl (133 μmol/l) for ≥1 day.

RESULTS: Infants whose mothers had received indomethacin for tocolysis were more likely than matched controls to have RI (9 of 37 vs 2 of 37, p=0.04). Among infants of indomethacin-treated mothers with elevated Cr, serum Cr remained ≥1.5 mg/dl (133 μmol/l) for a median of 6 days and >1.0 mg/dl (88 μmol/l) for a median of 19 days. The peak Cr and length of elevation were closely correlated (r2=0.63, p<0.0001).

CONCLUSION: Antenatal indomethacin can result in significant, prolonged RI in the infant. It may pose important risks to renal function and homeostasis in premature infants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Zuckerman H, Reiss U, Ribinstein I . Inhibition of human premature labor by indomethacin Obstet Gynecol 1974 44: 787–92

    CAS  PubMed  Google Scholar 

  2. Macones G, Robinson C . Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits Am J Obstet Gynecol 1988 177: 819–24

    Article  Google Scholar 

  3. Baerts W, Fetter W, Hop W, Wallenburt H, Spritzer R, Sauer P . Cerebral lesions in preterm infants after tocolytic indomethacin Dev Med Child Neurol 1990 32: 910–8

    Article  CAS  Google Scholar 

  4. Vanhaesebrouck P, Thiery M, Leroy J et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin J Pediatr 1988 113: 738–43

    Article  CAS  Google Scholar 

  5. Norton M, Merrill J, Cooper B et al. Neonatal complications after the administration of indomethacin for preterm labor N Engl J Med 1993 329: 1602–7

    Article  CAS  Google Scholar 

  6. Nishikubo T, Takahashi Y, Nagakawa Y et al. Renal impairment in very low birthweight infants following antenatal indomethacin administration Acta Paediatr J 1994 36: 202–6

    Article  CAS  Google Scholar 

  7. Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorala O, Hallman N . Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor J Pediatr 1994 124: 782–8

    Article  CAS  Google Scholar 

  8. Major C, Lewis D, Harding J, Porto M, Garite T . Tocolysis with indomethacin increases the incidence of necrotising enterocolitis in the low birth weight neonate Am J Obstet Gynecol 1994 170: 102–6

    Article  CAS  Google Scholar 

  9. Itskovitz J, Abramovici H, Brandes J . Oligohydramnios, meconium and perinatal death concurrent with indomethacin treatment in human pregnancy J Reprod Med 1980 24: 137–40

    CAS  PubMed  Google Scholar 

  10. Cantor B, Tyler T, Nelson R, Stein G . Oligohydramnios and transient neonatal anuria. A possible association with the maternal use of prostaglandin synthetase inhibitors J Reprod Med 1980 24: 220–3

    CAS  PubMed  Google Scholar 

  11. Veersema D, De Jong P, Van Wijck J . Indomethacin and the fetal renal non functioning syndrome Eur J Obstet Gynecol Reprod Biol 1983 16: 113–21

    Article  CAS  Google Scholar 

  12. Heijden A, Provoost A, Nauta W et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure Pediatr Res 1988 24: 644–8

    Article  Google Scholar 

  13. Souter D, Harding J, McCowan L . Antenatal indomethacin-adverse fetal effects confirmed Aust N Z J Obstet Gynaecol 1998 38: 11–6

    Article  CAS  Google Scholar 

  14. Gerson A, Abbasi A, Johnson A et al. Safety and efficacy of long-term tocolysis with indomethacin Am J Perinatol 1990 7: 71–4

    Article  CAS  Google Scholar 

  15. Miall L, Henderson M, Turner A et al. Plasma creatinine rises dramatically in the first 48 hours of life in preterm infants Pediatrics 1999 104: 1–4

    Article  Google Scholar 

  16. Baenziger O, Waldvogel K, Ghelfi D et al. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study Klin Padiatr 1999 211: 438–41

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butler-O'Hara, M., D'Angio, C. Risk of Persistent Renal Insufficiency in Premature Infants Following the Prenatal Use of Indomethacin for Suppression of Preterm Labor. J Perinatol 22, 541–546 (2002). https://doi.org/10.1038/sj.jp.7210790

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210790

This article is cited by

Search

Quick links